Here we focused on the role of the immune system in cancer progression, and on the development of cancer immunotherapies.
|
Organizers |
Institution |
Therese Sorlie |
Oslo University Hospital |
Vanessa Dumeaux |
McGill Universiy |
Michael Hallett |
McGill University |
|
|
Organizing committee |
Bjorn Fjukstad |
The Arctic University of Norway |
Silje Nord |
Oslo University Hospital |
Ali Madani |
Princess Margaret Hospital, U of Toronto |
Einar Holsbo |
The Arctic University of Norway |
Allen Zhang |
University of British Columbia |
|
|
Invitees |
|
Dana Pe’er |
Columbia University |
Fraser Symmans |
MD Anderson |
Quaid Morris |
University of Toronto |
Jens Lagergren |
KTH |
Benjamin Haibe-Kains |
Princess Margaret Hospital, U of Toronto |
Paul Boutros |
OICR, U of Toronto |
Johan Vallon Christersson |
Lund University |
Jim Lorens |
University of Bergen |
Markus Ringner |
SciLife Lab |
Kalle Malmberg |
Oslo University Hospital |
Daniel De Carvalho |
UHN, U of Toronto |
Joaquim Arribas |
Vall D’Hebron Insitute of Oncology |
Nils Halberg |
University of Bergen |
Juri Reimand |
OICR, U of Toronto |
Pam Ohashi |
UHN, U of Toronto |
Jenn Listgarten |
Microsoft Research |
Brad Nelson |
BC Cancer Agency |
Ole Christian Lingjaerde |
Oslo University |
Andrew McPherson |
University of British Columbia |
Sylvie Mader |
IRIC, U of Montreal |
Bob Clarke |
Georgetown University |
Rejean Lapointe |
CRCHUM, U of Montreal |
John Stagg |
University of Montreal |
Sandra Pommey |
University of Montreal |
E. John Werry |
University of Pennsylvania |
Jonathan Irish |
Vanderbilt University |
Rebecca Ihrie |
Vanderbilt University |
Christos Hatzis |
Yale University |
Celine Laumont |
IRIC, U of Montreal |
Claudia Kleinman |
Jewish General Hospital and McGill |
Etienne Gagnon |
IRIC, U of Montreal |
Mark Basik |
Jewish General Hospital and McGill |
Alex Rubinsteyn |
Mount Sinai hospital, NY |